Subscribe


PD breaking news – Pfizer to close Sydney plant

Pfizer to phase out Sydney manufacturing by the end of 2015.

Prizer has just announced the closure of its manufacturing operations in Sydney, with about 140 jobs affected.

The factory produces solid oral dose products – tablets and capsules – in the human and animal health area.

“This has been a difficult decision, and reflects the need to align our global manufacturing capacity with the needs of our business,” said Manufacturing Operations Director, Justin Mathie.

“Pfizer has been reviewing our global manufacturing network and capacity in response to changing global demand as a result of the patent expiry of a number of key medicines,” Mathie added.

“In addition our industry is seeing a trend away from high-volume medicines, to high value but lower volume medicines that target a specific patient population or disease condition,” he said, with this necessitating more flexible manufacturing facilities and a different overall approach.

Pfizer’s Perth facility will continue to manufacture sterile injectables for the domestic and export markets.

The closure has no impact on Pfizer’s commercial operations or the supply of its medicines in Australia.

More information in tomorrow’s Pharmacy Daily.


The above Breaking News Alert was sent to Pharmacy Daily subscribers on 26 Sep 13

Make a comment...



Established in 2007, Pharmacy Daily is Australia's leading pharmacy industry publication, and is sent as a free subscription to people across the industry as a PDF newsletter every weekday.

Register for Pharmacy Daily trial subscription

To sign up for a free subscription, click on the button at right.

Click here to see a sample issue of Pharmacy Daily.

Click here for more information on subscriptions.

Alternatively, you can search our site via the search box on the right hand side of the page, or find other content below.

Recent Pharmacy Daily articles

22 Jan

Weekly Comment 22 Jan 18 - WELCOME to PD's weekly comment feature. This ...


22 Jan

Dispensary Corner 22 Jan 18 - MEDICINAL marijuana is the subject of several ...


22 Jan

FDA pings Delta Labs - THE US Food and Drug Administration (FDA) ...


22 Jan

S3 ad clarification - THE Therapeutic Goods Administration has stressed that ...


22 Jan

Opioid consultation - OPTIONS for a regulatory response to opioid ...


22 Jan

Metformin recall - APOTEX is recallilng one patch of APO-Metformin ...


22 Jan

API warns of slow sales - AUSTRALIAN Pharmaceutical Industries this morning alerted investors ...


22 Jan

Concern over CM ad changes - THE Federal government has been accused of ...


19 Jan

Dispensary Corner 19 Jan 18 - IT MAKES perfect sense for the operation ...


19 Jan

PBA data released - THE Pharmacy Board of Australia has released ...


19 Jan

‘Out of pocket pain’ - THE Consumers Health Forum (CHF) has announced ...


19 Jan

Cannabis PBS listing? - VICTORIAN Health Minister Jill Hennessy has confirmed ...


19 Jan

Industrial hemp meet - THE Australian Industrial Hemp Conference is calling ...


19 Jan

S3 advertising permitted - THE Therapeutic Goods Administration has confirmed that ...


19 Jan

Codeine story ‘misleading’ - WHILE the rescheduling of products containing codeine ...


18 Jan

Travel Specials 18 Jan 18 - VIEW & Verandah Sale by Holland America ...


18 Jan

Dispensary Corner 18 Jan 18 - NEWLYWEDS from Northern Ireland have wasted no ...


18 Jan

CW float speculation - THE owners of Chemist Warehouse may be ...


18 Jan

Life-Long Learning - THE Australian Pharmacy Council has announced the ...


18 Jan

FIP Glasgow regos - REGISTRATIONS have opened for the 78th International ...



Show Pharmacy Daily items by month: